Bertil Olsson
81 – 90 of 161
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2004
-
Mark
Concealed conduction and dual pathway physiology of the atrioventricular node
(
- Contribution to journal › Article
-
Mark
Deterioration of interatrial conduction in patients with paroxysmal atrial fibrillation: Electroanatomic mapping of the right atrium and coronary sinus.
(
- Contribution to journal › Article
-
Mark
Ximelagatran or warfarin in atrial fibrillation? Reply
(
- Contribution to journal › Letter
-
Mark
Atrial fibrillatory frequency, atrial fibrillatory rate, or atrial cycle length--does it matter?
(
- Contribution to journal › Letter
- 2003
-
Mark
Ximelagatran Compared with Warfarain for prevention of thromboembolism in patients with nonvalvular atiral fibrillaton: Rationale. Objectives and design of a pair of clinical trials and baseline patient characteristics (SPORTIF III and V).
(
- Contribution to journal › Article
-
Mark
Electroanatomic mapping of right atrial activation in patients with and without paroxysmal atrial fibrillation
(
- Contribution to journal › Article
-
Mark
Left Atrial Conduction along the Coronary Sinus during Ectopic Atrial Tachycardia and Atrial Fibrillation: A Study Using Correlation Function Analysis
(
- Contribution to journal › Article
-
Mark
Does low-energy ultrasound, known to enhance thrombolysis, affect the size of ischemic brain damage?
(
- Contribution to journal › Article
-
Mark
Echocardiographic and electrocardiographic predictors for atrial fibrillation recurrence following cardioversion
(
- Contribution to journal › Article
-
Mark
Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial.
(
- Contribution to journal › Article